6934 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
HCmed Innovations Co Ltd. provides platforms for inhalation therapy using mesh technology. Its products include Pulmogine and AdheResp. The firm offers comprehensive aerosol characterization analytical services to support the development and optimization of inhalation products. It also offers analytical support in compliance with Pharmacopoeia guidelines. The company was founded by Jason Cheng, Leon Tsai, Shaogi Huang and Simon Hsieh on October 06, 2014 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6934 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company